| DB ID | MyCo_7113 |
| Title | Serum (1,3)-beta-D-glucan is an inefficient marker of breakthrough candidemia |
| Year | 2014 |
| PMID | 25349254 |
| Fungal Diseases involved | Candidemia |
| Associated Medical Condition | None |
| Genus | Candida |
| Species | krusei |
| Organism | Candida krusei |
| Ethical Statement | This investigation was approved by the Human Ethics Review Committee of Toranomon Hospital. |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | BDG |
| Biomarker Full Name | 1-3-beta-D-Glucan |
| Biomarker Type | Negative |
| Biomolecule | Protein |
| Geographical Location | Japan |
| Cohort | During the study period, a total of 147 cases of candidemia were identified, and 31 patients met the criteria for breakthrough candidemia. Serum BDG levels were measured in 25 patients with breakthrough candidemia and 67 patients with nonbreakthrough candidemia. |
| Cohort No. | 147 |
| Age Group | 22-95 |
| P Value | p=.01 |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Assay |
| Analysis Method | Wako turbidimetric assay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Wako turbidimetric assay |
| Up Regulation Down Regulation | Negative |
| Sequence Data | None |
| External Link | None |
